Jon Cuthbert

Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q2 revenue of $3.33 billion, up 12%, as its CF and newer treatments generated growth.

Alexander’s (NYSE:ALX) reported Q2 net income of $155.4 million, or $30.24 per diluted share, following a major property-sale gain.

AstraZeneca (NASDAQ:AZN) has reportedly engaged in early-stage negotiations regarding a potential merger with Bristol Myers Squibb (NYSE:BMY).

Lindblad Expeditions Holdings (NASDAQ:LIND) reported Q2 tour revenue of $199.2 million, up 19% year over year.

Integer Holdings (NYSE:ITGR) agreed to a $5.7 billion all-cash acquisition by KKR, giving shareholders $127 for each share.

BP (NYSE:BP) completed the sale of its Gelsenkirchen refinery and related German businesses to Klesch Group, targeting around $1 billion in lower underlying operating expenditure.

ZeroStack warned about its ability to continue operating after recording an US$82.5 million digital asset loss.

Atkore (NYSE:ATKR) reported fiscal 2026 third-quarter net sales of $794.8 million, up 8.1%, while adjusted earnings reached $1.92 per diluted share.

Spark shelved its consumer app indefinitely and now supplies crypto infrastructure to platforms including Robinhood.

Bitcoin (CRYPTO:BTC) traded near $63,382 as analyst Aksel Kibar identified a possible inverse head-and-shoulders reversal pattern.